Navigation Links
UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
Date:2/21/2008

COLLEGE PARK, Md., Feb. 21 /PRNewswire-USNewswire/ -- The University of Maryland's Maryland Industrial Partnerships Program (MIPS) today announces the approval of 18 new collaborative research projects between Maryland companies and university faculty.

Worth $4.4 million, the new projects combine $3 million from participating companies and $1.4 million from the Maryland Industrial Partnerships Program.

Through MIPS, faculty members engage in research that furthers the development of high-tech products for Maryland companies. Projects, which must be technology-focused and possess commercial potential, can range from creating or testing new products to clinical and pre-clinical trials.

Both the company and the University of Maryland contribute funding for each project. All funding goes to the participating faculty.

Four University System of Maryland campuses have approved projects. Three participating companies are based in Baltimore, two are on the Eastern Shore, one is in Southern Maryland, and one is near Annapolis, while the remaining ten are in Frederick, Gaithersburg, and near the Capital Beltway.

Projects approved, listed by participating company, university, project title and total project funding, include:

-- Salisbury-based AHPharma Food Safety Products Inc. and the University of Maryland Eastern Shore: Underwater Pulsed Arc Discharge (UPAD) for Poultry; $251,703

-- Arnold-based Applied Sensor Research and Development Corp. and the University of Maryland, College Park: Porous Packaging for Microfluidic Sensors; $97,112.

-- Frederick-based BioElectronics Corporation and the University of Maryland, Baltimore: Pulsed Electromagnetic Therapy for Healing; $258,788.

-- Baltimore-based CCC Diagnostics LLC and the University of Maryland, Baltimore: Clinical Studies of Drug Response Indicators Test; $732,700.

-- Baltimore-based CSA Medical Inc. and the University of Maryland, Baltimore: Multi-Center Dysplasia Study; $636,731.

-- Rockville-based Flexible Medical Systems LLC and the University of Maryland, Baltimore: Noninvasive Sensing of Glucose and Lactate; $219,974.

-- North Potomac-based Potomac Affinity Proteins LLC and the University of Maryland Biotechnology Institute: Proteases and Tags for Protein Purification; $135,000.

-- Hollywood-based Recovery Science LLC and the University of Maryland, College Park: Wrist Training Effects on Motor Performance: Golf; $350,870.

-- Potomac-based reoSYM and the University of Maryland, College Park: Compression for Future Ready Basestations; $195,700.

-- Rockville-based Rexahn Pharmaceuticals Inc. and the University of Maryland, Baltimore: Polymer-drug Conjugates for Cancer Therapy; $217,761.

-- Crisfield-based Sherwin Williams and the University of Maryland, College Park: Automation of the Brush-Knot Manufacturing Process; $77,572.

-- Rockville-based Signal Processing Inc. and the University of Maryland, College Park: Flexible and High Performance Biometric Tools; $121,505.

-- Gaithersburg-based Sirnaomics, Inc. and the University of Maryland, Baltimore: Silencing Scar Formation by Targeting Hoxb13: $158,199.

-- Silver Spring-based Technologies and Devices International Inc. and the University of Maryland, College Park: Material Study for Solid State Lighting; $37,144.

-- College Park-based TRX Systems Inc. and the University of Maryland, College Park: High Temperature Packaging & MEMS Characterization; $186,368.

-- Rockville-based VectorLogics Inc. and the University of Maryland Biotechnology Institute: Development of IBDV Vectors for Therapeutic Use; $143,749.

-- Baltimore-based WellDoc Communications, Inc. and the University of Maryland, Baltimore: Mobile Diabetes Management Platform; $443,595.

-- Boyds-based Zylacta Corporation and the University of Maryland Biotechnology Institute: Glycopeptides for Management of Hepatitis C; $138,200.

This is the 41st round of MIPS funding. The program has supported research projects with over 400 different Maryland companies since 1987.

Groundbreaking products such as Martek Biosciences' infant formula additives, Hughes Network Systems' HughesNet, MedImmune Inc.'s Synagis, and Black & Decker's Bullet Speed Tip Masonry Drill Bit have benefited from MIPS-supported research. These products have collectively generated more than $14.4 billion in revenue and led to the creation of thousands of jobs in Maryland.

About MIPS (http://www.mips.umd.edu)

The Maryland Industrial Partnerships Program, an initiative of the A. James Clark School of Engineering's Maryland Technology Enterprise Institute (Mtech), brings university innovation to the commercial sector by supporting university-based research projects to help Maryland companies develop technology-based products.


'/>"/>
SOURCE University of Maryland
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Potential Breakthrough Cancer Treatment Emerges from MIPS-Funded Clinical Trial Teaming CSA Medical Inc. and University of Maryland Researchers
2. HealthMedias Strongest Single Quarter Results: Growth Driven by Product Enhancements, New Partnerships
3. UCLA Program Aims to Revolutionize Kidney Transplants
4. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
5. CuraGen Provides Update on Velafermin, Belinostat and CR011-vcMMAE Clinical Development Programs
6. Kosan Opens Registration Program for Lead Hsp90 Inhibitor, Tanespimycin, in Multiple Myeloma
7. Phase 2a Multi-Dose Study Initiated by MedImmune in Patients With Asthma to Further Expand Anti-Interleukin-9 Program
8. Avicena Scientific Collaborator Advances Program for Using Energy Enhancing Molecules to Treat Neuromuscular Diseases
9. Diamyd Updates Gene Therapy Program and Outlines Plans for Phase I Clinical Trial for Treatment of Cancer Pain
10. Memory Pharmaceuticals Commences Phase 1 Clinical Program for R4996/MEM 63908
11. King Pharmaceuticals and Palatin Technologies Delay Immediate Plans for Phase 3 Clinical Program With Bremelanotide for Erectile Dysfunction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2017)... , July 10, 2017  The tenth annual ... Boston, MA at the Sheraton Boston ... and unparalleled access to global decision makers and innovative ... 800+ life science leaders during two impactful days. BioPharm ... provides delegates with additional networking opportunities with 4,500+ life ...
(Date:7/5/2017)... July 5, 2017 Oramed Pharmaceuticals ... ), a clinical-stage pharmaceutical company focused on the ... has received approval from the Israel Securities Authority to dual-list ... Oramed common stock will commence trading on the TASE on ... current market capitalization of the Company, it is expected that ...
(Date:6/30/2017)... ROCKVILLE, Md. , June 30, 2017 ... that since the start of May, at least ten ... financings include private investments, public offerings and a loan ... $3.3 million to almost $80 million.  Kalorama Information provides ... customers of its Diagnostics Knowledge Center. ...
Breaking Medicine Technology:
(Date:7/23/2017)... ... July 23, 2017 , ... Scientists from the University of Exeter ... of high-intensity, weight-bearing activity equivalent to a medium-paced run for pre-menopausal women, or a ... who specializes in total spine care, I understand the importance exercise can play on ...
(Date:7/23/2017)... (PRWEB) , ... July 23, 2017 , ... ... has joined Florida Pain Relief Group – Melbourne, a practice owned by Physician ... certification in interventional pain management, Dr. Stern also is certified in pediatrics, emergency ...
(Date:7/22/2017)... ... July 22, 2017 , ... The arthroscopic ... repairs the opportunity to return to sports and jobs that require heavy physical ... Sports Medicine’s Annual Meeting in Toronto, Ontario, Canada. , “We studied ...
(Date:7/21/2017)... ... July 21, 2017 , ... Roderick Crabbe ... services to families and business owners in northern Florida, is joining the First ... support to area adults with developmental challenges. , The First Coast YMCA offers ...
(Date:7/21/2017)... ... July 21, 2017 , ... Hospital M&A activity slowed in the second ... of hospital acquisitions rose to 23 in the second quarter, up 15% from the ... the 20 announced deals in the year-ago second quarter. Only four of the transactions ...
Breaking Medicine News(10 mins):